Edition:
United Kingdom

Humanwell Healthcare Group Co Ltd (600079.SS)

600079.SS on Shanghai Stock Exchange

15.05CNY
14 Feb 2018
Change (% chg)

¥-0.15 (-0.99%)
Prev Close
¥15.20
Open
¥15.22
Day's High
¥15.26
Day's Low
¥14.98
Volume
5,371,822
Avg. Vol
12,468,968
52-wk High
¥21.50
52-wk Low
¥14.53

Latest Key Developments (Source: Significant Developments)

Humanwell Healthcare Group issues 2018 first tranche short-term financing notes worth 1 bln yuan
Wednesday, 24 Jan 2018 

Jan 24 (Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS>:Says it issued 2018 first tranche short-term financing notes worth 1 billion yuan with a term of 365 days and coupon rate of 5.49 percent .Bank of China Limited served as the main underwriter .  Full Article

Humanwell Healthcare Group sells bio-pharma firm for 350 mln yuan
Tuesday, 26 Dec 2017 

Dec 26 (Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS>:Says it sold 100 percent stake in Yichang-based bio-pharma firm for 350 million yuan .  Full Article

Humanwell Healthcare's Unit To Boost Capital Of Lifestyles Healthcare
Tuesday, 19 Dec 2017 

Dec 19 (Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS>::SAYS UNIT SIGNS AGREEMENT TO BOOST CAPITAL OF LIFESTYLES HEALTHCARE PTE WITH HEALTH PRODUCTS FIRM'S 59 PERCENT STAKE WORTH $131.1 MILLION.  Full Article

Humanwell Healthcare Group completes investment in unit RFSW Investment Pte Ltd
Friday, 15 Dec 2017 

Dec 15 (Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS> ::Says it invested 805.4 million yuan in wholly owned Singapore unit RFSW Investment Pte. Ltd.Jissbon, a Wuhan-based commodities company, becomes controlling subsidiary of RFSW Investment Pte. Ltd after equity investment .  Full Article

Humanwell Healthcare Group unit gets approval of clinical trial for Meisuoshuli tablets
Wednesday, 6 Dec 2017 

Dec 6 (Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS> ::Says its Wuhan-based unit gets approval of clinical trial for Meisuoshuli tablets, which is used for anti-inflammatory, analgesic and antipyretic .  Full Article

Humanwell Healthcare's shareholder bought shares worth 143.7 mln yuan during Jun 28-Nov 29
Wednesday, 29 Nov 2017 

Nov 29 (Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS>::SAYS CONTROLLING SHAREHOLDER HAS BOUGHT 143.7 MILLION YUAN ($21.78 million) WORTH OF COMPANY SHARES BETWEEN JUNE 28 AND NOV 29.  Full Article

Humanwell Healthcare Group unit passes FDA approval
Thursday, 23 Nov 2017 

Nov 23(Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS>:Says its 75 percent-owned unit received approval for its soft capsule named Dutasteride Capsule from U.S Food and Drug Administration .Says the unit will be able to sell Dutasteride Capsule in the United States after receiving the FDA approval.  Full Article

Humanwell Healthcare to sell bio-pharma firm for 350 mln yuan
Wednesday, 22 Nov 2017 

Nov 22 (Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS>:Says it plans to sell bio-pharma firm for 350 million yuan ($52.90 million).  Full Article

Humanwell Healthcare and unit to increase stake in Tianfeng Securities
Friday, 10 Nov 2017 

Nov 10 (Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS>:Says it and unit plan to acquire additional 2.18 percent stake in Tianfeng Securities for 305.1 million yuan ($45.97 million).  Full Article

Humanwell Healthcare Group completes issuance of 67.7 mln A shares in private placement
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS> ::Says it completed issuance of 67.7 million A shares of the company and raised 1.19 billion yuan in private placement .  Full Article

UPDATE 2-Australia's Ansell profit up six-fold after condom business sale

* Shares jump, but give up gains and hit 2-wk low (Recasts; adds CFO quote and rubber price outlook)